Elevation Oncology

About:

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

Website: https://elevationoncology.com/

Top Investors: Samsara BioCapital, Cormorant Asset Management, venBio Partners, K2 HealthVentures, Boxer Capital

Description:

Elevation Oncology makes genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Its lead candidate, seribantumab, which inhibits tumor growth driven by NRG1 fusions, is currently being clinically tested in the Phase 2 CRESTONE study for patients with tumors of any origin that have an NRG1 fusion.